Michael E. Thase, MD

ASCP Corner

Monoamine Oxidase Inhibitors Revisited: What You Should Know

February 15, 2013

Michael E. Thase, Joseph F. Goldberg

Supplement Article

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 27, 2012

Michael E. Thase, Larry Culpepper, Robert M. A. Hirschfeld, et al

Supplement Article

The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines

July 27, 2012

Michael E. Thase

Original Research

A Randomized, Double-Blind, Placebo-Controlled 8-Week Trial of the Efficacy and Tolerability of Multiple Doses of Lu AA21004 in Adults With Major Depressive Disorder

July 15, 2012

Michael E. Thase, Neven Henigsberg, Atul R. Mahableshwarkar, et al

Article

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 15, 2012

Michael E. Thase, Larry Culpepper, Robert M. A. Hirschfeld, et al

Educational Activity

MAOIs and Depression Treatment Guidelines

July 15, 2012

Michael E. Thase

Article

The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines

July 15, 2012

Michael E. Thase

Educational Activity

Applying Antidepressant Study Results to Clinical Practice

June 15, 2012

Michael E. Thase

Original Research

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

May 15, 2012

Michael E. Thase, Ashwin A. Patkar, Chi-Un Pae, et al

Educational Activity

Bipolar Disorder Maintenance Treatment: Monitoring Effectiveness and Safety

April 15, 2012

Michael E. Thase

Educational Activity

Strategies for Increasing Treatment Adherence in Bipolar Disorder

February 15, 2012

Michael E. Thase

Educational Activity

Using Adjunctive Treatments When First-Line Antidepressants Fail

January 15, 2012

Michael E. Thase

Monoamine Oxidase Inhibitors Revisited: What You Should Know

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines

A Randomized, Double-Blind, Placebo-Controlled 8-Week Trial of the Efficacy and Tolerability of Multiple Doses of Lu AA21004 in Adults With Major Depressive Disorder

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

MAOIs and Depression Treatment Guidelines

The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines

Applying Antidepressant Study Results to Clinical Practice

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

Bipolar Disorder Maintenance Treatment: Monitoring Effectiveness and Safety

Strategies for Increasing Treatment Adherence in Bipolar Disorder

Using Adjunctive Treatments When First-Line Antidepressants Fail

ELSEWHERE:

FOLLOW US:

Michael E. Thase, MD

Monoamine Oxidase Inhibitors Revisited: What You Should Know

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines

A Randomized, Double-Blind, Placebo-Controlled 8-Week Trial of the Efficacy and Tolerability of Multiple Doses of Lu AA21004 in Adults With Major Depressive Disorder

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

MAOIs and Depression Treatment Guidelines

The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines

Applying Antidepressant Study Results to Clinical Practice

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

Bipolar Disorder Maintenance Treatment: Monitoring Effectiveness and Safety

Strategies for Increasing Treatment Adherence in Bipolar Disorder

Using Adjunctive Treatments When First-Line Antidepressants Fail

Insightful. Evidence-based. Human-centered.

Subscribe to readmore articles

Subscribe to read
more articles